Egunov O A, Afanasiev S A, Kondratieva D S, Muslimova E F, Stepanov I V, Grishin A S, Mikheeva E R, Boshchenko A A
Cardiology Research Institute, Tomsk National Research Medical Center, Tomsk, Russia.
Iconlab LLC, Nizhny Novgorod, Russia.
Bull Exp Biol Med. 2024 Nov;178(1):163-168. doi: 10.1007/s10517-024-06300-y. Epub 2024 Nov 25.
The effectiveness and safety of two types of samples based on a biocompatible polymer material made of methacrylic oligomers (Reperen) as a potential antiadhesion pericardial barrier were evaluated in in vitro and in vivo experiments. Two kinds of samples, reinforced with a polyamide mesh and without reinforcement, were used. In in vitro experiments, no adhesion and aggregation of human fibroblasts to the test samples were detected. In in vivo experiments, the samples implanted to rats into the thigh muscles were easily separated from the surrounding tissues 1, 2, and 3 weeks after implantation, being weakly fixed only in the area of the edges. Histological examination at week 2 after implantation revealed no differences between the experimental and control groups. At week 1 and 3, fibrosis and inflammation were more pronounced in animals of the control group (with simulated implantation). The properties demonstrated by both samples of Reperen barriers (with and without polyamide mesh reinforcement) in vivo and in vitro allow considering them as a potential antiadhesion pericardial barrier for clinical use.
在体外和体内实验中,评估了两种基于由甲基丙烯酸低聚物制成的生物相容性聚合物材料(Reperen)的样品作为潜在的心包抗粘连屏障的有效性和安全性。使用了两种样品,一种用聚酰胺网增强,另一种未增强。在体外实验中,未检测到人类成纤维细胞与测试样品的粘连和聚集。在体内实验中,植入大鼠大腿肌肉的样品在植入后1、2和3周很容易与周围组织分离,仅在边缘区域固定较弱。植入后第2周的组织学检查显示实验组和对照组之间没有差异。在第1周和第3周,对照组(模拟植入)动物的纤维化和炎症更为明显。Reperen屏障的两种样品(有和没有聚酰胺网增强)在体内和体外表现出的特性使其可被视为潜在的临床心包抗粘连屏障。